CA2068888A1 - Methode de mesure des antigenes de surface des lymphocytes t chez les humains - Google Patents

Methode de mesure des antigenes de surface des lymphocytes t chez les humains

Info

Publication number
CA2068888A1
CA2068888A1 CA002068888A CA2068888A CA2068888A1 CA 2068888 A1 CA2068888 A1 CA 2068888A1 CA 002068888 A CA002068888 A CA 002068888A CA 2068888 A CA2068888 A CA 2068888A CA 2068888 A1 CA2068888 A1 CA 2068888A1
Authority
CA
Canada
Prior art keywords
beta
cells
cell
body fluid
fluid sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002068888A
Other languages
English (en)
Inventor
Brian L. Kotzin
Philippa Marrack
John Kappler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Jewish Health
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/437,370 external-priority patent/US5336598A/en
Application filed by Individual filed Critical Individual
Publication of CA2068888A1 publication Critical patent/CA2068888A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Ecology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002068888A 1989-11-15 1990-11-13 Methode de mesure des antigenes de surface des lymphocytes t chez les humains Abandoned CA2068888A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US437,370 1989-11-15
US07/437,370 US5336598A (en) 1989-11-15 1989-11-15 Method for diagnosing a superantigen caused pathologial condition via assay of T-cells
US48835390A 1990-03-02 1990-03-02
US488,353 1990-03-02

Publications (1)

Publication Number Publication Date
CA2068888A1 true CA2068888A1 (fr) 1991-05-16

Family

ID=27031293

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002068888A Abandoned CA2068888A1 (fr) 1989-11-15 1990-11-13 Methode de mesure des antigenes de surface des lymphocytes t chez les humains

Country Status (7)

Country Link
EP (1) EP0500780A4 (fr)
JP (1) JPH05504621A (fr)
KR (1) KR920703844A (fr)
AU (1) AU651346B2 (fr)
CA (1) CA2068888A1 (fr)
FI (1) FI922197A (fr)
WO (1) WO1991007508A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2116526A1 (fr) * 1991-08-28 1993-03-18 William V. Williams Therapie basee sur les recepteurs des cellules t contre l'arthrite rhumatoide
FR2736831B1 (fr) * 1995-07-19 1997-08-22 Centre Nat Rech Scient Sequences nucleotidiques et peptidiques pour le traitement de la myasthenie
JP2002512692A (ja) * 1997-05-27 2002-04-23 ユニヴァーシティ オヴ ウェールズ カレッジ オヴ メディスン 傷の回復を評価する方法
JP2018517711A (ja) 2015-06-01 2018-07-05 メディジーン イミュノテラピーズ ゲーエムベーハー 細胞表面タンパク質に対する抗体を作製する方法
EP3303389A1 (fr) * 2015-06-01 2018-04-11 Medigene Immunotherapies GmbH Anticorps spécifiques à des récepteurs de lymphocytes t
WO2016193299A1 (fr) 2015-06-01 2016-12-08 Medigene Immunotherapies Gmbh Bibliothèque de récepteurs de lymphocytes t
HUE053674T2 (hu) 2015-12-23 2021-07-28 Medigene Immunotherapies Gmbh Antigén-specifikus TCR receptorok új generációja

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677061A (en) * 1984-10-19 1987-06-30 Genetic Systems Corporation T-cell lymphocyte subset monitoring of immunologic disease
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4667061A (en) * 1985-04-02 1987-05-19 Hitachi, Ltd. Gas insulated apparatus with internal coated insulation layer of high dielectric constant
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
US5340921A (en) * 1986-07-03 1994-08-23 T Cell Sciences, Inc. Γ, δT cell receptor and methods and detection
CA1305912C (fr) * 1987-06-22 1992-08-04 Richard J. Albertini Detection d'amplification de lymphocytes
FI891226A (fi) * 1988-04-28 1989-10-29 Univ Leland Stanford Junior Reseptordeterminanter i anti-t-celler foer behandling av autoimmunsjukdom.
KR900702370A (ko) * 1988-10-06 1990-12-06 제임스 디. 그랜트 가용성 t세포 표면분자를 사용하는 치료 및 진단방법

Also Published As

Publication number Publication date
FI922197A0 (fi) 1992-05-14
WO1991007508A1 (fr) 1991-05-30
KR920703844A (ko) 1992-12-18
AU7787391A (en) 1991-06-13
EP0500780A4 (en) 1993-03-10
FI922197A (fi) 1992-05-14
AU651346B2 (en) 1994-07-21
JPH05504621A (ja) 1993-07-15
EP0500780A1 (fr) 1992-09-02

Similar Documents

Publication Publication Date Title
US5336598A (en) Method for diagnosing a superantigen caused pathologial condition via assay of T-cells
Trabattoni et al. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression
Albani et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis
Connors et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
Taner et al. Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year
AU2008301240B2 (en) A method for identifying antigen-specific regulatory T cells
Ramage et al. T cell responses to heat-shock protein 60: differential responses by CD4+ T cell subsets according to their expression of CD45 isotypes
JP5925184B2 (ja) Ｍｙｃｏｂａｃｔｅｒｉｕｍｔｕｂｅｒｃｕｌｏｓｉｓ感染と関連した患者状況のｉｎｖｉｔｒｏ迅速判定法
Bembridge et al. CD45RO expression on bovine T cells: relation to biological function.
JP2023011814A (ja) 糖尿病バイオマーカ
WO2006012641A2 (fr) Procedes de detection et de traitement de troubles auto-immuns
Krishnan et al. Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3ζ expression
SILVA et al. Analysis of T cells recruited during delayed‐type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection
Eggenhuizen et al. Heterologous immunity between SARS-CoV-2 and pathogenic bacteria
JP2016531284A (ja) 炎症性腸疾患の診断、予後予測、及び処置
Zhang et al. A polyclonal anti‐vaccine CD4 T cell response detected with HLA‐DP4 multimers in a melanoma patient vaccinated with MAGE‐3. DP4‐peptide‐pulsed dendritic cells
CA2068888A1 (fr) Methode de mesure des antigenes de surface des lymphocytes t chez les humains
Blumerman et al. Comparison of gene expression by co-cultured WC1+ γδ and CD4+ αβ T cells exhibiting a recall response to bacterial antigen
Uchida et al. Escherichia coli–Specific CD4+ T cells have public T-cell Receptors and low interleukin 10 production in Crohn’s disease
Balmas et al. Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes
Macchia et al. Expression of CD8α identifies a distinct subset of effector memory CD4+ T lymphocytes
WO2016115253A1 (fr) Mimotopes de l'insuline et leurs méthodes d'utilisation
Sassi et al. Mechanisms of the natural reactivity of lymphocytes from noninfected individuals to membrane-associated Leishmania infantum antigens
Cotugno et al. Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine
Cottrez et al. Selective CD4+ T cell deletion after specific activation in HIV-infected individuals; protection by anti-CD28 monoclonal antibodies

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead